Interpace BioPharma, LLC
Parsippany
New Jersey
07054
United States
3 articles about Interpace BioPharma, LLC
-
Interpace Biosciences Announces Third Quarter 2022 Financial and Business Results Sale of Pharma Significantly Improves Liquidity Resulting in Removal of Going Concern
11/14/2022
Interpace Biosciences, Inc. announced financial results for the third quarter ended September 30, 2022 and provided a business and financial update.
-
Interpace Biosciences Announces Second Quarter 2022 Financial and Business Results and New Clinical Validation Data; Diagnostic Accuracy Significantly Improved
8/15/2022
Interpace Biosciences, Inc. announced financial results for the second quarter ended June 30, 2022 and provided a business and financial update.
-
PDI, Inc. Announces $55 Million Agreement to Market Rx Product Through 2013 for Treatment of Knee Pain, Deal is Entered Through Newly Formed Business Unit, Interpace BioPharma, LLC
8/1/2011